Risedronate is in a class of drugs called bisphosphonates used for the treatment of Paget's disease of bone (in which the formation of bone is abnormal) and in persons with osteoporosis (in which the density and strength of bones are reduced).
The global Risedronate market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Risedronate is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Risedronate is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Risedronate is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Risedronate include Merck, Amgen, Teva, Mylan, Apotex, Sanofi, Abbott, Novartis and Tecoland, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Risedronate, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Risedronate, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Risedronate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Risedronate sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Risedronate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Risedronate sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Teva
Mylan
Apotex
Sanofi
Abbott
Novartis
Tecoland
Taj Pharmaceuticals
Segment by Type
5 mg Tablets
35 mg Tablets
75 mg Tablets
150 mg Tablets
Segment by Application
Postmenopausal Osteoporosis
Men with Osteoporosis
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Risedronate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Risedronate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Risedronate sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Risedronate Product Introduction
1.2 Market by Type
1.2.1 Global Risedronate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 5 mg Tablets
1.2.3 35 mg Tablets
1.2.4 75 mg Tablets
1.2.5 150 mg Tablets
1.3 Market by Application
1.3.1 Global Risedronate Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Postmenopausal Osteoporosis
1.3.3 Men with Osteoporosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Risedronate Sales Estimates and Forecasts 2019-2030
2.2 Global Risedronate Revenue by Region
2.2.1 Global Risedronate Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Risedronate Revenue by Region (2019-2024)
2.2.3 Global Risedronate Revenue by Region (2025-2030)
2.2.4 Global Risedronate Revenue Market Share by Region (2019-2030)
2.3 Global Risedronate Sales Estimates and Forecasts 2019-2030
2.4 Global Risedronate Sales by Region
2.4.1 Global Risedronate Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Risedronate Sales by Region (2019-2024)
2.4.3 Global Risedronate Sales by Region (2025-2030)
2.4.4 Global Risedronate Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Risedronate Sales by Manufacturers
3.1.1 Global Risedronate Sales by Manufacturers (2019-2024)
3.1.2 Global Risedronate Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Risedronate in 2023
3.2 Global Risedronate Revenue by Manufacturers
3.2.1 Global Risedronate Revenue by Manufacturers (2019-2024)
3.2.2 Global Risedronate Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Risedronate Revenue in 2023
3.3 Global Key Players of Risedronate, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Risedronate Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Risedronate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Risedronate, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Risedronate, Product Offered and Application
3.8 Global Key Manufacturers of Risedronate, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Risedronate Sales by Type
4.1.1 Global Risedronate Historical Sales by Type (2019-2024)
4.1.2 Global Risedronate Forecasted Sales by Type (2025-2030)
4.1.3 Global Risedronate Sales Market Share by Type (2019-2030)
4.2 Global Risedronate Revenue by Type
4.2.1 Global Risedronate Historical Revenue by Type (2019-2024)
4.2.2 Global Risedronate Forecasted Revenue by Type (2025-2030)
4.2.3 Global Risedronate Revenue Market Share by Type (2019-2030)
4.3 Global Risedronate Price by Type
4.3.1 Global Risedronate Price by Type (2019-2024)
4.3.2 Global Risedronate Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Risedronate Sales by Application
5.1.1 Global Risedronate Historical Sales by Application (2019-2024)
5.1.2 Global Risedronate Forecasted Sales by Application (2025-2030)
5.1.3 Global Risedronate Sales Market Share by Application (2019-2030)
5.2 Global Risedronate Revenue by Application
5.2.1 Global Risedronate Historical Revenue by Application (2019-2024)
5.2.2 Global Risedronate Forecasted Revenue by Application (2025-2030)
5.2.3 Global Risedronate Revenue Market Share by Application (2019-2030)
5.3 Global Risedronate Price by Application
5.3.1 Global Risedronate Price by Application (2019-2024)
5.3.2 Global Risedronate Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Risedronate Market Size by Type
6.1.1 US & Canada Risedronate Sales by Type (2019-2030)
6.1.2 US & Canada Risedronate Revenue by Type (2019-2030)
6.2 US & Canada Risedronate Market Size by Application
6.2.1 US & Canada Risedronate Sales by Application (2019-2030)
6.2.2 US & Canada Risedronate Revenue by Application (2019-2030)
6.3 US & Canada Risedronate Market Size by Country
6.3.1 US & Canada Risedronate Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Risedronate Sales by Country (2019-2030)
6.3.3 US & Canada Risedronate Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Risedronate Market Size by Type
7.1.1 Europe Risedronate Sales by Type (2019-2030)
7.1.2 Europe Risedronate Revenue by Type (2019-2030)
7.2 Europe Risedronate Market Size by Application
7.2.1 Europe Risedronate Sales by Application (2019-2030)
7.2.2 Europe Risedronate Revenue by Application (2019-2030)
7.3 Europe Risedronate Market Size by Country
7.3.1 Europe Risedronate Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Risedronate Sales by Country (2019-2030)
7.3.3 Europe Risedronate Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Risedronate Market Size
8.1.1 China Risedronate Sales (2019-2030)
8.1.2 China Risedronate Revenue (2019-2030)
8.2 China Risedronate Market Size by Application
8.2.1 China Risedronate Sales by Application (2019-2030)
8.2.2 China Risedronate Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Risedronate Market Size by Type
9.1.1 Asia Risedronate Sales by Type (2019-2030)
9.1.2 Asia Risedronate Revenue by Type (2019-2030)
9.2 Asia Risedronate Market Size by Application
9.2.1 Asia Risedronate Sales by Application (2019-2030)
9.2.2 Asia Risedronate Revenue by Application (2019-2030)
9.3 Asia Risedronate Sales by Region
9.3.1 Asia Risedronate Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Risedronate Revenue by Region (2019-2030)
9.3.3 Asia Risedronate Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Risedronate Market Size by Type
10.1.1 Middle East, Africa and Latin America Risedronate Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Risedronate Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Risedronate Market Size by Application
10.2.1 Middle East, Africa and Latin America Risedronate Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Risedronate Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Risedronate Sales by Country
10.3.1 Middle East, Africa and Latin America Risedronate Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Risedronate Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Risedronate Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Overview
11.2.3 Amgen Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Amgen Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Teva Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Overview
11.4.3 Mylan Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Mylan Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Apotex
11.5.1 Apotex Company Information
11.5.2 Apotex Overview
11.5.3 Apotex Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Apotex Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Apotex Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi Overview
11.6.3 Sanofi Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Sanofi Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Recent Developments
11.7 Abbott
11.7.1 Abbott Company Information
11.7.2 Abbott Overview
11.7.3 Abbott Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Abbott Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbott Recent Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Overview
11.8.3 Novartis Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Novartis Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis Recent Developments
11.9 Tecoland
11.9.1 Tecoland Company Information
11.9.2 Tecoland Overview
11.9.3 Tecoland Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Tecoland Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Tecoland Recent Developments
11.10 Taj Pharmaceuticals
11.10.1 Taj Pharmaceuticals Company Information
11.10.2 Taj Pharmaceuticals Overview
11.10.3 Taj Pharmaceuticals Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Taj Pharmaceuticals Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Taj Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Risedronate Industry Chain Analysis
12.2 Risedronate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Risedronate Production Mode & Process
12.4 Risedronate Sales and Marketing
12.4.1 Risedronate Sales Channels
12.4.2 Risedronate Distributors
12.5 Risedronate Customers
13 Market Dynamics
13.1 Risedronate Industry Trends
13.2 Risedronate Market Drivers
13.3 Risedronate Market Challenges
13.4 Risedronate Market Restraints
14 Key Findings in The Global Risedronate Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Merck
Amgen
Teva
Mylan
Apotex
Sanofi
Abbott
Novartis
Tecoland
Taj Pharmaceuticals
听
听
*If Applicable.